Hemoadsorption with CytoSorb(®) and the early course of linezolid plasma concentration during septic shock

Hemoadsorption with CytoSorb(®) becomes increasingly established in treatment of various, predominantly inflammation-associated diseases. In septic shock, results suggest improvements in hemodynamics and organ function. However, little is known about the in vivo adsorption properties for various ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Köhler, Thomas, Schwier, Elke, Kirchner, Carmen, Winde, Günther, Henzler, Dietrich, Eickmeyer, Claas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866295/
https://www.ncbi.nlm.nih.gov/pubmed/34047868
http://dx.doi.org/10.1007/s10047-021-01274-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866295/
https://www.ncbi.nlm.nih.gov/pubmed/34047868
http://dx.doi.org/10.1007/s10047-021-01274-4

Ejemplares similares